These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
128 related items for PubMed ID: 8251071
1. The effect of placement of tryptophan residues in selected A-chain positions on the biological profile of insulin. Chu YC, Burke GT, Ross JB, Katsoyannis PG. J Protein Chem; 1993 Aug; 12(4):499-505. PubMed ID: 8251071 [Abstract] [Full Text] [Related]
2. Synthesis of an insulin analogue embodying a strongly fluorescent moiety, [19-tryptophan-A]insulin. Ohta N, Burke GT, Katsoyannis PG. J Protein Chem; 1988 Feb; 7(1):55-65. PubMed ID: 3076448 [Abstract] [Full Text] [Related]
3. The A14 position of insulin tolerates considerable structural alterations with modest effects on the biological behavior of the hormone. Chu YC, Zong L, Burke GT, Katsoyannis PG. J Protein Chem; 1992 Oct; 11(5):571-7. PubMed ID: 1360216 [Abstract] [Full Text] [Related]
4. Divergence of the in vitro biological activity and receptor binding affinity of a synthetic insulin analogue, [21-asparaginamide-A]insulin. Burke GT, Chanley JD, Okada Y, Cosmatos A, Ferderigos N, Katsoyannis PG. Biochemistry; 1980 Sep 30; 19(20):4547-56. PubMed ID: 7000179 [Abstract] [Full Text] [Related]
5. A biologically active insulin analogue with modification in the A2 position. [2-Valine-A] sheep insulin. Ohta N, Burke GT, Katsoyannis PG. Chem Pharm Bull (Tokyo); 1989 Mar 30; 37(3):670-4. PubMed ID: 2665960 [Abstract] [Full Text] [Related]
6. Insight into the conformational dynamics of specific regions of porcine pancreatic phospholipase A2 from a time-resolved fluorescence study of a genetically inserted single tryptophan residue. Kuipers OP, Vincent M, Brochon JC, Verheij HM, de Haas GH, Gallay J. Biochemistry; 1991 Sep 10; 30(36):8771-85. PubMed ID: 1888737 [Abstract] [Full Text] [Related]
7. The biological properties of insulins with tyrosine replaced by phenylalanine at positions 14 and 19 of the A chain. Cockram CS, Jones RH, Sönksen PH. Diabet Med; 1985 Jul 10; 2(4):241-4. PubMed ID: 2951075 [Abstract] [Full Text] [Related]
8. Importance of aliphatic side-chain structure at positions 2 and 3 of the insulin A chain in insulin-receptor interactions. Nakagawa SH, Tager HS. Biochemistry; 1992 Mar 31; 31(12):3204-14. PubMed ID: 1554705 [Abstract] [Full Text] [Related]
9. Insulin analogues with modifications at position B26. Divergence of binding affinity and biological activity. Záková L, Kazdová L, Hanclová I, Protivínská E, Sanda M, Budesínský M, Jirácek J. Biochemistry; 2008 May 27; 47(21):5858-68. PubMed ID: 18452310 [Abstract] [Full Text] [Related]
10. Receptor binding and biological activity of specifically labeled [125I]- and [127I]monoiodoinsulin isomers in isolated rat adipocytes. Peavy DE, Abram JD, Frank BH, Duckworth WC. Endocrinology; 1984 May 27; 114(5):1818-24. PubMed ID: 6370667 [Abstract] [Full Text] [Related]
18. Comparison of biologic potency of human insulin (recombinant DNA) and purified porcine insulin (PPI) on the rat and human adipocyte lipogenesis model. Khokher MA, Dandona P. Diabetes Care; 1982 Sep 13; 5 Suppl 2():102-3. PubMed ID: 6765517 [Abstract] [Full Text] [Related]